Here are the reasons for top movers today
Tuesday, Jan 2, 2024 4:48 pm ET
Longboard Pharmaceuticals stock gained as the company announced positive topline data from its PACIFIC Study evaluating bexicaserin for the treatment of Developmental and Epileptic Encephalopathies (DEEs).